Koji Eshima
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 10%
Papers in
- Immunology 33
- Immune Cell Function and Interaction 24
- Immunotherapy and Immune Responses 17
- T-cell and B-cell Immunology 16
- Immune Response and Inflammation 5
-
- Angiogenesis and VEGF in Cancer 7
- Co-authors
- Yoshiya Ito (21 shared papers)Masataka Majima (20 shared papers)Kazuya Iwabuchi (13 shared papers)Hideki Amano (16 shared papers)Harumi Suzuki (7 shared papers)Fumihiro Ogawa (8 shared papers)Nobukata Shinohara (10 shared papers)Shuh Narumiya (6 shared papers)
- Journals
- Immunology (5 papers)Biomedicine & Pharmacotherapy (4 papers)PLoS ONE (4 papers)The Journal of Immunology (3 papers)Cardiovascular Research (2 papers)
- Partner nations
- JapanUnited StatesSweden
In The Last Decade
Koji Eshima
52 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 79
- Immunology 475
- Oncology 242
- Hepatology 70
- Cancer Research 88
- Genetics 55
Countries citing papers authored by Koji Eshima
This map shows the geographic impact of Koji Eshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Eshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Eshima more than expected).
Fields of papers citing papers by Koji Eshima
This network shows the impact of papers produced by Koji Eshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Eshima. The network helps show where Koji Eshima may publish in the future.
Co-authors
The 25 scholars most cited alongside Koji Eshima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 81 | |
| 2 | 2014 | 78 | |
| 3 | 2000 | 62 | |
| 4 | 2012 | 55 | |
| 5 | 2009 | 54 | |
| 6 | 2018 | 48 | |
| 7 | 2012 | 40 | |
| 8 | 2011 | 38 | |
| 9 | 2014 | 35 | |
| 10 | 2016 | 33 | |
| 11 | 2015 | 33 | |
| 12 | 2010 | 31 | |
| 13 | 2012 | 30 | |
| 14 | 2013 | 28 | |
| 15 | 2010 | 28 | |
| 16 | 2019 | 27 | |
| 17 | 1997 | 26 | |
| 18 | 2019 | 25 | |
| 19 | 2015 | 22 | |
| 20 | 1994 | 21 |
About Koji Eshima
Koji Eshima is a scholar working on Immunology, Molecular Biology, Oncology, Surgery and Cancer Research, having authored 54 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (24 papers), Immunotherapy and Immune Responses (17 papers), T-cell and B-cell Immunology (16 papers), Angiogenesis and VEGF in Cancer (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immune Response and Inflammation (5 papers), NF-κB Signaling Pathways (4 papers) and Inflammatory mediators and NSAID effects (4 papers). The work is most often cited by research in Immunology (475 citations), Oncology (242 citations), Hepatology (70 citations), Cancer Research (88 citations) and Genetics (55 citations). Koji Eshima has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Yoshiya Ito, Masataka Majima, Kazuya Iwabuchi, Hideki Amano, Harumi Suzuki, Fumihiro Ogawa, Nobukata Shinohara, Shuh Narumiya, Yukitoshi Satoh and Hidero Kitasato. Their work appears in journals such as Immunology, Biomedicine & Pharmacotherapy, PLoS ONE, The Journal of Immunology and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.